ATR (AptarGroup) Risk Assessment

View and export this data going back to 1993. Start your Free Trial

What is AptarGroup Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of AptarGroup is: Low Risk: Strong fundamentals, worth long-term holding.

Competitive Comparison of AptarGroup's Risk Assessment

For the Medical Instruments & Supplies subindustry, AptarGroup's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

AptarGroup's Risk Assessment Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, AptarGroup's Risk Assessment distribution charts can be found below:

* The bar in red indicates where AptarGroup's Risk Assessment falls into.

Save Embed

;

Save Embed

;

AptarGroup (NYSE:ATR) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

AptarGroup Risk Assessment Related Terms

Thank you for viewing the detailed overview of AptarGroup's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

AptarGroup Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » AptarGroup Inc (NYSE:ATR) » Definitions » Risk Assessment

Comparable Companies

Traded in Other Exchanges

AGT:Germany AGT:Germany

Address

265 Exchange Drive, Suite 301, Crystal Lake, IL, USA, 60014

Website

https://www.aptar.com

Headquartered in Crystal Lake, Illinois, AptarGroup is a leading global supplier of dispensing systems such as aerosol valves, pumps, closures, and elastomer packaging components to the consumer goods and pharmaceutical markets. With the bulk of its annual net sales coming from Europe (49% of sales) and the United States (32%), Aptar aims to increase its presence in Asia (11%) and Latin America (8%). It operates three business segments, Pharma, Beauty, and Closures. Pharma generates over two thirds of group profits.

Executives

Monnas Giovanna Kampouri	director	C/O APTARGROUP, INC., 265 EXCHANGE DRIVE, SUITE 100, CRYSTAL LAKE IL 60014
Kimberly Chainey	officer: EVP and General Counsel	265 EXCHANGE DRIVE, SUITE 100, CRYSTAL LAKE IL 60014
Marc Prieur	officer: Segment President	265 EXCHANGE DRIVE, SUITE 100, CRYSTAL LAKE IL 60014
Stephan B. Tanda	director, officer: President and CEO	C/O PATHEON N.V., HERENGRACHT 483, AMSTERDAM P7 1017 BT
Hedi Tlili	officer: Segment President	265 EXCHANGE DRIVE, SUITE 100, CRYSTAL LAKE IL 60014
Gael Touya	officer: Segment President	475 W. TERRA COTTA AVE., SUITE E, CRYSTAL LAKE IL 60014
Shiela Vinczeller	officer: Chief Human Resource Officer	265 EXCHANGE DRIVE, SUITE 100, CRYSTAL LAKE IL 60014
Robert Kuhn	officer: EVP & CFO	C/O APTARGROUP 475 W. TERRA COTTA AVENUE, SUITE E, CRYSTAL LAKE IL 60014
Xiangwei Gong	officer: President, Asia	265 EXCHANGE DRIVE, SUITE 100, CRYSTAL LAKE IL 60010
Sarah Js Glickman	director	60 BINNEY STREET, C/O BLUEBIRD BIO, INC., CAMBRIDGE MA 02142
George L Fotiades	director	281 SUMMIT AVENUE, SUMMIT NJ 07901
Julie Xing	director	265 EXCHANGE DRIVE, SUITE 301, CRYSTAL LAKE IL 60014
Maritza Gomez Montiel	director	C/O APTARGROUP, INC., 265 EXCHANGE DRIVE, SUITE 100, CRYSTAL LAKE IL 60014
Matthew L. Trerotola	director	2711 CENTERVILLE ROAD, SUITE 400, WILMINGTON DE 19808
Ralf K. Wunderlich	director	C/O APTARGROUP, INC., 265 EXCHANGE DRIVE, SUITE 100, CRYSTAL LAKE IL 60014